Cell line · CVCL_1288
Papers67
1 more article gives this line's RRID in its Methods without naming the line nearby, so it is not listed.
1 to 20 of 67
Download this page as JSON| Paper | Journal | Year | How we know | Retracted | Source |
|---|---|---|---|---|---|
| NLRX1 contributes to immunotherapeutic resistance of head and neck squamous cell carcinoma by suppressing type I interferon pathway. | Front Immunol | 2026 | Its Methods give the RRID and name the line | PubMed | |
| SLC15A4 promotes oral cancer progression by regulating TLR9 and activating the JAK/STAT signaling pathway. | Head Face Med | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Maackia amurensis seed lectin inhibits oral squamous cell carcinoma tumorigenesis by suppressing N6-methyladenosine modification-mediated SRY-box transcription factor 2 expression. | J Int Med Res | 2026 | Its Methods give the RRID and name the line | PubMed | |
| ENOX2 (tNOX)-Associated Stemness in Oral Cancer Cells and Its Clinical Correlation in Head and Neck Tumors. | Antioxidants (Basel) | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Distinct Regulation of the ARF and TAp73 Tumor Suppressor Genes by the Transcription Factor E2F1 Enables Discrimination of Cancer Cells from Normal Growing Cells. | Cells | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Tempeh Extract and HSC-3 Cell Migration: An In Vitro Study. | Asian Pac J Cancer Prev | 2025 | Its Methods give the RRID and name the line | PubMed | |
| Quantitative and longitudinal monitoring of cancer cell invasion in a three-dimensional in vitro model of oral cancer using optical coherence tomography. | Sci Rep | 2025 | Its Methods give the RRID and name the line | PubMed | |
| Therapeutic stress triggers tumor STAT1 acetylation to disarm immunotherapy. | Cell Rep Med | 2025 | Its Methods give the RRID and name the line | PubMed | |
| Mortalin Represents a Promising Therapeutic Target for Oral Cancers: Clinical Relevance and Experimental Evidence for the Activation of Akt/mTOR Signaling. | Cancers (Basel) | 2025 | Its Methods give the RRID and name the line | PubMed | |
| In vitro assessment of BBI608 in 2D and 3D culture models for drug repositioning in oral squamous cell carcinoma. | Oncol Rep | 2025 | Its Methods give the RRID and name the line | PubMed | |
| EGFRvIII-driven microenvironmental fibroblast activation and transformation accelerate oral cancer progression via lipocalin-2/STAT3 axis. | Neoplasia | 2025 | Its Methods give the RRID and name the line | PubMed | |
| TRPV4 activation in Schwann cells mediates mechanically induced pain of oral cancer. | Front Pain Res (Lausanne) | 2025 | Its Methods give the RRID and name the line | PubMed | |
| The PTTG1/VASP axis promotes oral squamous cell carcinoma metastasis by modulating focal adhesion and actin filaments. | Mol Oncol | 2025 | Its Methods give the RRID and name the line | PubMed | |
| Tribbles pseudokinase 3 drives cancer stemness in oral squamous cell carcinoma cells by supporting the expression levels of SOX2 and EGFR. | Int J Mol Med | 2025 | Its Methods give the RRID and name the line | PubMed | |
| Development and Characterization of a Three-Dimensional Organotypic In Vitro Oral Cancer Model with Four Co-Cultured Cell Types, Including Patient-Derived Cancer-Associated Fibroblasts. | Biomedicines | 2024 | Its Methods give the RRID and name the line | PubMed | |
| Multispectral fluorescence imaging of EGFR and PD-L1 for precision detection of oral squamous cell carcinoma: a preclinical and clinical study. | BMC Med | 2024 | Its Methods give the RRID and name the line | PubMed | |
| Hypoxia-Induced Long Noncoding RNA HIF1A-AS2 Regulates Stability of MHC Class I Protein in Head and Neck Cancer. | Cancer Immunol Res | 2024 | Its Methods give the RRID and name the line | PubMed | |
| Thymidylate synthase disruption to limit cell proliferation in cell therapies. | Mol Ther | 2024 | Its Methods give the RRID and name the line | PubMed | |
| Identification of MUC1-C as a Target for Suppressing Progression of Head and Neck Squamous Cell Carcinomas. | Cancer Res Commun | 2024 | Its Methods give the RRID and name the line | PubMed | |
| Interplay of p62-mTORC1 and EGFR signaling promotes cisplatin resistance in oral cancer. | Heliyon | 2024 | Its Methods give the RRID and name the line | PubMed |
cell-lines-2026-11-14-0.1.0
Sources 4
- CellosaurusCC BY 4.0, with credit to Cellosaurus (SIB)
- PubMed Central's articlesTitles shown only for CC0, CC BY and public domain articles
- NLM's PMC Article DatasetsCourtesy of NLM, which does not endorse this database
- PubMedNLM's terms
Each source's terms
- CellosaurusCC BY 4.0. Cellosaurus's README: "we have chosen to apply the Creative Commons Attribution 4.0 International (CC BY 4.0) license to Cellosaurus (https://creativecommons.org/licenses/by/4.0/). This means that you are free to copy and redistribute Cellosaurus in any medium or format. You can remix, transform, and build upon Cellosaurus for any purpose, even commercially. You must give appropriate credit, provide a link to the license, and indicate if changes were made." Copyright (c) CALIPHO group, SIB Swiss Institute of Bioinformatics. Read on 14 Nov 2026 at https://ftp.expasy.org/databases/cellosaurus/README
- PubMed Central's articlesEach article's own license. Its words show only under CC0, CC BY or public domain
- NLM's PMC Article DatasetsNLM's PMC Article Datasets on AWS, https://registry.opendata.aws/ncbi-pmc. Its terms: users "acknowledge NLM as the source of the data in a clear and conspicuous manner", do not use the PubMed Central wordmark or the PMC logo, do not "indicate or imply that NLM/NIH/HHS has endorsed" a product, and "only distribute data that are licensed for redistribution". Each article keeps its own license: https://pmc.ncbi.nlm.nih.gov/about/copyright/
- PubMedNLM's terms
Cellosaurus, SIB Swiss Institute of Bioinformatics, https://www.cellosaurus.org, CC BY 4.0. Its problem notes are given in its own words.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/cell-lines/v1/CVCL_1288/papers